In recent work8, in an attempt to predict such post-transcriptional axes, we predicted in silico potential Cx43 mRNA-circRNAs-miRNAs biomarker signatures for early-onset breast cancer risk assessment, which might recapitulate phenotypes observed upon Cx43 loss14,37,48,49. The gene discussed is GJA1; the disease is breast cancer.